Psilocybin is Being Studied as a Potential Aid for Depression in Early Alzheimer’s Disease

Have you recently been diagnosed with Alzheimer’s Disease? Are you feeling depressed? Sign up to participate in a research study examining a unique approach to depression in people with Mild Cognitive Impairment (MCI) or early Alzheimer’s Disease (AD).

Researchers at Johns Hopkins University are studying psilocybin – a psychoactive substance found in certain kinds of mushrooms – to see whether it can help people with depression and Alzheimer’s Disease when administered in a safe and supportive setting. Volunteers will additionally receive free counseling.

To find out more about this study, call 410-550-5466.

Principal Investigators: Albert Garcia-Romeu, Ph.D. & Paul B. Rosenberg, M.D., Protocol: IRB00175915